Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 7, 1996, Pages 1334-1340

  Shima, David T ^a   Gougos, Anne ^b   Miller, Joan W ^a   Tolentino, Michael ^a   Robinson, Gerald ^a   Adamis, Anthony P ^a,b   D'Amore, Patricia A ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HYBRIDON INC   (United States)

Author keywords

angiogenesis; ganglion cells; hypoxia; in situ hybridization; neovascularization

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; VASCULOTROPIN;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; GENE EXPRESSION REGULATION; IN SITU HYBRIDIZATION; MACACA; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLOTTING, SOUTHERN; CLONING, MOLECULAR; DNA PRIMERS; DNA, COMPLEMENTARY; ELECTROPHORESIS, AGAR GEL; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION; IN SITU HYBRIDIZATION; IRIS; ISCHEMIA; LASER COAGULATION; LYMPHOKINES; MACACA FASCICULARIS; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PATHOLOGIC; POLYMERASE CHAIN REACTION; RETINA; RETINAL VEIN OCCLUSION; RETINAL VESSELS; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0029888871     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Klagsbrun M, Soker S. VEGF/VPF: The angiogenesis factor found? Curr Biol. 1994;3:699-702.
2. Miller JW, Adamis AP, Shima DT, et al. Vascular permeability endothelial cell growth factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol. 1994;145:574-584.
3. Ashton N, Ward B, Serpell G. Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia. Br J Ophthalmol. 1954;38:397-432.
4. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359:843-845.
5. Shima DT, Adamis AP, Yeo K-T, et al. Hypoxic induction of endothelial cell growth factors in retinal cells: Identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med. 1995;1:182-193.
6. Adamis AP, Miller JW, Bernal M-T, et al. Elevated vascular permeability factor/vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol. 1994;118:445-450.
7. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other ocular disorders. New Engl J Med. 1994;331:1480-1487.
8. Malecaze F, Clamens S, Simorre-Pinatel V, et al. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Lab Sci. 1994;112:1476-1482.
9. McGookin ED, Stopa EG, Kuo-LeBlanc V, et al. Vascular endothelial cell growth factor (VEGF) has a different distribution than basic fibroblast growth factor (bFGF) in the adult human retina. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1992;15:821.
10. Tischer E, Gospodarowicz D, Mitchell R, et al. Vascular endothelial growth factor: A new member of the platelet-derived growth factor gene family. Biochem Biophys Res Comm. 1989;165:1198-1206.
11. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem. 1992;257:26031-26037.
12. Kim KJ, Li B, Winer J, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature. 1993;362:841-844.
13. Adamis AP, Shima DT, Tolentino MJ, et al. Inhibition of VEGF prevents ocular neovascularization in a primate. Arch Ophthalmol 1996;114:66-71.
14. Freyler H, Egerer I. Secotrial diabetic retinopathy in a case of partial atrophy of the optic nerve. Klinische Monatasblatter fur Augenheilkunde. 1975;166:227-233.
15. Beetham WP, Aiello LM, Balodimos MC, Koncz L. Ruby laser photocoagulation of early diabetic neovascular retinopathy. Arch Ophthalmol. 1970;83:261.
16. Wolbarsht ML, Landers MBI. The rationale of photocoagulation therapy for proliferative diabetic retinopathy: A review and a model. Ophthalmic Surg. 1980; 11:235-245.
17. Flower RW, Patz A. The effect of hyperbaric oxygenation on retinal ischemia. Invest Ophthalmol. 1971; 10:605-616.
18. Pournaras CJ, Tsacoupoulos M, Strommer K, Gilodi N, Leuenberger PM. Scatter photocoagulation reverses tissue hypoxia in experimental vasoproliferative microangiopathy in miniature pigs. Ophthalmology. 1990;97:1329-1333.
19. Stone J, Itin A, Alon T, et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci. 1995;15:4738-4747.
20. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LEH. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA. 1995; 92:905-909.
21. Chan-Ling T, Stone J. Degeneration of astrocytes in feline retinopathy of prematurity causes failure of the blood-brain barrier. Invest Ophthalmol Vis Sci. 1992; 33:2145-2159.
22. Breier G, Albrecht U, Sterrer S, Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development. 1992;114:521-532.